Ekso Bionics Holdings, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDEkso Bionics Holdings, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 98), indicating clear outperformance against the broad market. Earnings contraction of 18% provides fundamental context to the price action. However, price is extended 73% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $17.66 | +29.92% | ABOVE |
| 50 SMA | $13.28 | +72.85% | ABOVE |
| 100 SMA | $11.48 | +99.98% | ABOVE |
| 150 SMA | $9.24 | +148.33% | ABOVE |
| 200 SMA | $7.98 | +187.49% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is EKSO in an uptrend right now?
EKSO has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, EKSO is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is EKSO overbought or oversold?
EKSO's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is EKSO outperforming the market?
EKSO has a Relative Strength (RS) Rating of 98 out of 99. Yes, EKSO is a market leader, outperforming 98% of all stocks over the past 12 months.
Where is EKSO in its 52-week range?
EKSO is trading at $22.95, which is 81% of its 52-week high ($28.20) and 79% above its 52-week low ($2.91).
How volatile is EKSO?
EKSO has a Beta of 3.06 and 52-week volatility of 157%. It's more volatile than the S&P 500 - expect bigger swings.